Cancer Genetics – News and Features

Researchers have demonstrated that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor microenvironment.

The study reveals that patients diagnosed with womb cancer are often not tested for Lynch syndrome, a genetic condition that significantly increases the risk of developing multiple cancers, including womb and bowel cancer.

A new study from researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine provides fresh insights into how cancers evolve when they metastasize.

Researchers have developed a new machine learning algorithm, SAVANA, which can accurately identify cancer-specific structural variations and copy number aberrations in long-read DNA sequencing data, informing cancer diagnosis and interventions.

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene promotes and sustains lymphoma development and progression, paving the way for novel targeted therapies.

The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even space travel, according to a new study.

The evidence was revealed in a new study by scientists from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences, which deciphered the evolutionary patterns of cold adaptation during rice's northward expansion.

A research team at the University of Würzburg has gained new insights into the development of kidney tumors in young children. These enable a better risk assessment and could form the basis for targeted screening and improved early detection.

Scientists investigating the impact of climate change on women’s health have found that increased heat is linked to an increase in rates of breast, ovarian, uterine and cervical cancers.

Historically, most research in neurodegenerative disease has focused on targeting neurons in the brain. In a new study, researchers instead identified a new target: the blood–brain barrier.